David Pettigrew, DPhil has 15 years of experience in medical device and pharmaceutical product development. Prior to joining BrightInsight, he was Managing Director of Sagentia, a technology and product development consulting firm. During his time at Sagentia, he served a range of large multinational healthcare clients, with particular focus on development strategies for integrating connectivity into higher risk medical devices such as in vitro diagnostic instruments, implantable neurostimulators and autoinjectors. He has also participated in FDA discussion panels on (regulated) mobile medical apps.
His early career focused on developing sensors for point of care microfluidic diagnostic instruments, most notably the world's first clinical analyzer for measuring the anaesthetic propofol in whole blood. His work in diagnostics has resulted in several CE mark and FDA 510k approvals
David holds a DPhil from the University of Oxford, UK in Molecular Biophysics, where he used X-Ray Crystallography and Electron Microscopy to explore host-pathogen interactions at the molecular level.